logo

Vertex Pharmaceuticals Inc. (VRTX)



Trade VRTX now with
  Date
  Headline
8/4/2022 4:40:02 PM Vertex Pharmaceuticals Inc. (VRTX) Has Raised Its FY22 Revenue Estimate To $8.6 to $8.8 Bln From $8.4 to $8.6 Bln
8/4/2022 4:14:34 PM Vertex Pharma Q2 EPS $3.13 Vs. $0.26 Year Ago
7/11/2022 8:05:10 AM Vertex To Acquire ViaCyte For $320 Mln In Cash
7/5/2022 8:02:54 AM Vertex : FDA Lifts Clinical Hold On VX-880 Phase 1/2 Trial For Treatment Of Type 1 Diabetes
6/8/2022 8:03:42 AM Vertex's Inaxaplin Granted Breakthrough Therapy Designation By FDA And Priority Medicines Designation By EMA
6/2/2022 10:21:57 AM Vertex And CRISPR Announce Acceptance Of Late-Breaking Abstract For CTX001 At 2022 Annual EHA Congress
5/31/2022 8:07:48 AM Vertex To Present New Data On VX-880 Clinical Trial
5/5/2022 4:26:21 PM Vertex Pharma Q1 EPS $2.96 Vs. $2.49 Year Ago
5/2/2022 8:34:56 AM Vertex Updates On Phase 1/2 Clinical Trial Of VX-880 For Treatment Of Type 1 Diabetes